FindTrial
Sign In

HIV Disclosure and Medication Adherence, a Pilot Study

HIV Disclosure and Medication Adherence, a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01621412
Acronym
RSAD-VIH-11
Enrollment
120
Registered
2012-06-18
Start date
2012-04-01
Completion date
2013-06-01
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection

Keywords

Medication Adherence, HIV infection, Disclosure

Brief summary

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Detailed description

Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation. Adherence is measured by electronic monitoring and pill count.

Interventions

None listed

Sponsors

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Lead SponsorOTHER
Centre Hospitalier Universitaire Vaudois
CollaboratorOTHER
Swiss HIV Cohort Study
CollaboratorNETWORK

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV Infection * Enrolled in the adherence-enhancing program

Exclusion criteria

* Inclusion visit * Not french or english speaker

Design outcomes

Primary

MeasureTime frameDescription
Patient Adherence30 days before surveyElectronic monitoring of adherence during 30 days before survey

Secondary

MeasureTime frameDescription
Patient Adherence90 days before surveyElectronic monitoring of adherence during 90 days before survey

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORMarie-Paule Schneider, PhD

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

PRINCIPAL_INVESTIGATORAurélie Gertsch, PhD-Student

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

STUDY_CHAIROlivier Bugnon, Professor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

STUDY_CHAIRMatthias Cavassini, MD

Centre Hospitalier Universitaire Vaudois

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026